Clinical Trials

Phase NA Not yet recruiting

Advanced Gastric Cancer

NCT07371871 2026-01-28

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

30 enrolled

Advanced Gastric Cancer

NCT03223376 2025-12-01

FRUTIGA

Phase 3 Completed

703 enrolled

Advanced Gastric Cancer

NCT06346093 2025-06-10

Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

Phase NA Recruiting

124 enrolled

Advanced Gastric Cancer

NCT02142322 2025-04-17

Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer

52 enrolled

Advanced Gastric Cancer

NCT04195828 2025-04-01

Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

106 enrolled

Phase 2 Not yet recruiting

Advanced Gastric Cancer

NCT06706895 2024-11-27

A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer

21 enrolled

Phase 1/2 Not yet recruiting

Advanced Gastric Cancer

NCT06592287 2024-09-19

The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer

66 enrolled

Phase 2 Active not recruiting

Advanced Gastric Cancer

NCT03579784 2024-04-19

Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

40 enrolled

Advanced Gastric Cancer

NCT06169410 2024-01-23

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Phase 4 Unknown

140 enrolled

Advanced Gastric Cancer

NCT02935634 2023-06-09

FRACTION-GC

190 enrolled 25 charts

Advanced Gastric Cancer

NCT05584592 2022-10-18

A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients

170 enrolled

Advanced Gastric Cancer

NCT04890392 2021-08-12

Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

20 enrolled

Advanced Gastric Cancer

NCT04385641 2020-05-13

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

18 enrolled

Advanced Gastric Cancer

NCT04286711 2020-02-27

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Phase 1/2 Unknown

52 enrolled

Advanced Gastric Cancer

NCT00915382 2020-01-07

Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS

Phase 3 Completed

625 enrolled

Advanced Gastric Cancer

NCT00976768 2020-01-07

Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

44 enrolled

Advanced Gastric Cancer

NCT01049620 2020-01-07

RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX

Phase 1 Completed

40 enrolled

Advanced Gastric Cancer

NCT01471470 2020-01-07

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

31 enrolled

Advanced Gastric Cancer

NCT02451956 2019-12-30

Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy

21 enrolled

Advanced Gastric Cancer

NCT04182724 2019-12-03

Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer

Phase 1/2 Unknown

57 enrolled

Advanced Gastric Cancer

NCT03393416 2019-08-29

A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor

Phase 1 Unknown

28 enrolled

Advanced Gastric Cancer

NCT03954756 2019-05-17

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

35 enrolled

Advanced Gastric Cancer

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Phase 1 Unknown

21 enrolled

Advanced Gastric Cancer

NCT01503372 2019-02-12

PaFLO

75 enrolled

Advanced Gastric Cancer

NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Phase 2/3 Completed

120 enrolled

Advanced Gastric Cancer

NCT03449966 2019-01-11

Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status

55 enrolled

Advanced Gastric Cancer

NCT03564834 2018-09-28

Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients

180 enrolled

Advanced Gastric Cancer

NCT03255811 2017-08-21

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

40 enrolled

Advanced Gastric Cancer

NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

47 enrolled

Advanced Gastric Cancer

NCT01152853 2015-11-20

PF299804-AGC

28 enrolled

Advanced Gastric Cancer

NCT01136031 2015-05-20

TI-2ndAGC

Phase 1/2 Completed

42 enrolled

Advanced Gastric Cancer

NCT00842491 2015-05-19

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

45 enrolled

Advanced Gastric Cancer

NCT01015339 2015-05-19

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Phase 3 Unknown

320 enrolled

Advanced Gastric Cancer

NCT02123407 2014-04-25

Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer

Phase 3 Unknown

30 enrolled

Advanced Gastric Cancer

NCT02072317 2014-02-26

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

140 enrolled

Advanced Gastric Cancer

NCT02071043 2014-02-25

Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis

48 enrolled

Advanced Gastric Cancer

NCT02038621 2014-01-16

GZH-001

224 enrolled

Advanced Gastric Cancer

NCT01851941 2013-05-13

A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer

52 enrolled

Advanced Gastric Cancer

NCT01238055 2013-04-09

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

116 enrolled

Advanced Gastric Cancer

NCT00821990 2012-01-20

Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer

Phase 3 Completed

200 enrolled

Advanced Gastric Cancer

NCT00992199 2010-09-08

IPchemo-AGC

79 enrolled

Advanced Gastric Cancer

NCT00743964 2010-01-15

Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)

91 enrolled